Sign in
Taking people in United StatesNo phase

Surgery for brain metastases without dexamethasone around the operation

Tests skipping dexamethasone around surgery in adults with newly found brain metastases.

Key facts

Who runs it
University of Louisville
Where
Louisville, United StatesSee the site
Trial code
Registry title
MeDex: No Perioperative Dexamethasone in Brain Metastases
Status
Recruiting
People taking part
35 people, planned
Started
1 Aug 2026
Expected to end
Oct 2027
Type of study
Interventional
Treatments tested
  • Withholding perioperative Dexamethasone
Record updated
29 May 2026

Who can take part

The trial is looking for adults with newly found brain metastases (cancer spread to the brain) who are planned for surgery to remove them. They will have surgery without the steroid dexamethasone (Dex).

Age
18 years and older
Sex
All sexes
Disease stage
New brain tumor(s) on imaging and a mass in a body organ suspected or confirmed to be cancer. Brain surgery (craniotomy) is planned to remove more than 75% of the tumor. ECOG performance status ≤ 2 (up and about more than 50% of waking hours). Midline shift on MRI ≤ 10 mm.
Earlier treatment
Must never have received Dex. No steroid use in the past month. People with a lung mass and no prior diagnosis must have a lung biopsy before brain surgery.
Main reasons for not taking part
  • Brain metastases that cannot be removed by surgery and are over 2 cm (0.8 in), or more than 4 such metastases
  • Treatment with laser interstitial thermal therapy (LITT), or high concern for primary CNS lymphoma
  • Small cell lung carcinoma
  • A condition that needs steroids
  • Stage 4 chronic kidney disease (GFR<30), or being pregnant or breastfeeding
Show the full registry criteria (17)Hide the full registry criteria

Who can take part

  • New brain tumor(s) on imaging
  • Visceral mass(es) suspicious or confirmed for neoplasm; Patients with lung mass suspicious for primary lung cancer and no prior diagnosis must undergo biopsy of the lung mass prior to resection of brain metastasis(es) to exclude histology (i.e., small cell lung carcinoma) that would not benefit from resection
  • No contraindications for craniotomy
  • Age ≥ 18 years
  • ECOG performance status ≤ 2 (i.e., ambulatory > 50% of waking hours)
  • Midline shift on MRI ≤ 10 mm
  • Craniotomy planned to resect >75% of the enhancing mass (surgeon's judgment)

Who cannot take part

  • Presence of BMs not eligible for resection that are each > 2 cm in any one dimension
  • >4 BMs not eligible for resection that are each 2 cm in any one dimension
  • Treatment with laser interstitial thermal therapy (LITT)
  • Steroid use in the past month
  • A condition that requires steroids
  • Stage 4 chronic kidney disease (GFR<30)
  • High concern for primary CNS lymphoma
  • Diagnosis of small cell lung carcinoma
  • Any receipt of Dex
  • Pregnant or breastfeeding

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Brain metastases

This trial is currently available in United States.

  • University of Louisville HospitalLouisville, United StatesContact: Mechelle Kaufman, BSNTaking people

About the trial

What the trial wants to find out

Perioperative treatment of newly diagnosed cancer patients with brain metastasis without dexamethasone (Dex).

The group in the trial

  • Withholding perioperative dexamethasoneTreatment being tested

    The safety and feasibility of withholding perioperative dexamethasone (Dex) in newly diagnosed cancer patients undergoing resection of brain metastases (BMs). The primary question is not comparative efficacy, but rather whether it is safe to forgo Dex in this patient population.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
MeDex: No Perioperative Dexamethasone in Brain Metastases
Plain-language title
Surgery for brain metastases without dexamethasone around the operationGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07044557, who can take part
Record updated
29 May 2026